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word sal dit bes moontlik beteken dat die kursus Of verkort
kan word, Of meer studente ingeneem kan word. Hoe dit
ook sy, die grenslose verveling wat met nuttelose lesings
gepaard gaan sal die arme student gespaar bly.
Hoewel die omset van die bestaande skole indien moont-
lik vergroot moet word, bly dit noodsaaklik dat ons meer
mediese opleidingssentrums in die lewe moet roep. Die
fasiliteite is daar, ons moet slegs skouer aan die wiel sit
en die nodige organisasie inste!. Met die toenemende
industri·ele ontwikkeling het die hospitale verbonde aan die
verskillende mynkomplekse in so 'n mate ontwikkel dat
daar nou oorgenoeg onderwysmateriaal beskikbaar is, mits
die nodige toestemming tot gebruik van hierdie pasiente
vir opleiding verkry kan word. Met die oog op die dring-
ende landsbehoefte behoort ons nie te skroom om sodanige
toestemming op die hoogste vlak te reel nie. Leerkragte is
daar genoeg, mits die betrokke universiteite gewillig sal
wees om hulle 'n behoorlike salaris te betaal. Hopelik het
die tyd nou aangebreek dat ons na eeue, ja bykans jaar-
duisende, uiteindelik sal besef dat die geld wat aan goeie
leerkragte betaal word een van die beste beleggings is wat
'n volk kan maak.
Ons hoop om binnekort 'n nuwe morbiditeitsstudie as
bylaag tot die Tydskrif te publiseer en ons vertrou dat die
universiteitsowerhede hierdie keer gewillig sal wees om dit
die aandag te skenk wat dit verdien en om nie bang te
wees om selfs ingrypende veranderinge in die leerplan aan
te bring as die feite duidelik toon dat dit vir almal ten
beste sal wees nie.
l. Tobias. P. V. (1968): S. Afr. T. Geneesk., 42, 1240.
2. Van Biljon, P. J. (1957): Ibid., 31, 397.
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TABLE I. ACCURACY IN EVALUATION OF RH-ANTIBODY TITRES BY
STANDARDIZED INDIRECT ANTIGLOBULIN METHOD WHEN DETER-
MINED BY 2 INVESTIGATORS (BLIND TESn
the range of one dilution tube nearly 20% of inaccurate
results can be recorded for the same samples of blood
when tested by two investigators. For a 2-dilution-tube
difference the percentage of error is narrowed to 5%. The
absence of titration inaccuracies exceeding 3 dilution tubes
is significant in that an observed increase of this magni-
tude can confidently be regarded as a renewed episode of
immunization. Assuming that titre differences of 3 dilu-
tion tubes or more can also imply that transplacental pas-
sage of Rh-incompatible foetal red cells has taken place,
then it should also be possible to assess how often such
occurrences generally take place during pregnancy.
In no instance were mothers included in whom the pro-
duction of Rh antibodies might have been the result of pre-
vious Rh-incompatible blood transfusions, and only Rh-
incompatible mother-infant combinations were examined.
For the evaluation of Rh-antibody titres the standard-
ized method of indirect antiglobulin titration was used.'
The importance of thorough washing of Rh-sensitized
cells to avoid contamination by human serum before add-
ing antihuman globulin reagent is emphasized. The neces-
sity for this mode of testing, particularly for establishing
consistent titration results, was recently confirmed by
Gibbs and Camp."
Since the frequency of antenatal episodes of Rh im-
munization is known to differ in Rh-negative mothers who
become immunized by foetal Rh-positive red cells,'" the
question of when and how often these mothers do show
increased episodes of antibody production is important.
To determine these variations it is necessary that the in-
vestigator first resolves the accuracy of his indirect anti-

























Since the recent discovery that Rh-negative mothers can
be protected against Rh immunization by the passive
administration of anti-D gammaglobulin,'·2 considerable
attention has been focused on the incidence and effect of
foeto-maternal bleeds occurring at delivery. Evidence is
also available to show that foetal red cells often find their
way into the maternal circulation during pregnancy, indi-
cating that it is possible that antigenic stimuli for Rh-
antibody formation can be expected before, as well as
after, the delivery of an Rh-positive infant.3 • 1
Even though investigators employ different methods for
the antenatal detection of foetal red cells, there has always
been close agreement that the frequency of positive find-
ings increases during the final months of pregnancy. While
not every foeto-maternal bleed necessarily constitutes an
active process of iso-immunization (because individual
differences in the mechanism of antibody formation can
be expected), it nevertheless raises the problem that ante-
natal haemorrhage from the foetus to the mother can ini-
tiate or further the intensity of antibody stimulation. It
is therefore possible to postulate that recorded antenatal
variations in antibody specificity, nature of immuno-
globulin involved, or simple antibody titre differences can
be considered as evidence that renewed foetal bleeds have
taken place.
In this section of a three-part report, results of an in-
vestigation are presented to show that Rh-antibody follow-
up studies performed throughout pregnancy can often
clearly reveal the frequency of transplacental haemorrhage
and its effect on foetal wastage. Although past obser-
vations have consistently suggested that the initial de-
velopment of Rh immunization occurs as a result of the
trauma of parturition, it is also shown that such events
can occur as a consequence of foetal bleeds during
pregnancy.
*Paper presented at the Tational Blood Transfusion Congress held in Dur-
ban, July 1967.
tPresent address: 'atal Institute of Immunology, Durban.
MATERIALS AND METHODS
All Rh-immunized mothers analysed in this study were
examined from the first trimester of pregnancy onwards.
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• Represents Rh-antibody titre increase of 3 dilution tubes or more.
RESULTS AND DISCUSSION
Table II records an analysis of 818 Rh-negative mothers
who either were already immunized before the present
in the incidence of tran placental bleed occurring be-
tween mothers immunized and not immunized before the
present pregnancy, it would appear that the mo t likely
explanation for the decreased occurrence of episodes of
immunization is that the mother who is already immunized
has a remarkable ability to conceal the recognition of the
foetal Rh-positive antigen as a potential stimulus. Such a
hypothesis seems quite acceptable, particularly when we
consider that these mothers can only be the recipients of
foetal Rh-positive red cells which were already sensitized
in lI£ero, whereas mothers who were not immunized be-
fore the present pregnancy would be more often expo ed
to foetal red cells possessing the full expression of the Rh
antigen. As such, the mechanism of Rh-antibody stimula-
tion is unquestionably comparable with the tudies of Stern
et al." These investigators were able to show that sensi-
tized Rh-positive red cells are far less antigenic than un-
sensitized red cells, and their original work has led to the
evaluation of the prevention of Rh immunization by the
injection of gammaglobulin Rh antibodies.
If the present indication of apparent suppression of in-
creased antibody production is an accurate deduction of
the experimental findings of Stern eT al.," it can be een
that such a protective situation is not constant throughout
pregnancy. In fact, the observations show that this ap-
parent protection appears to decrease among the already
immunized mothers as pregnancy progresses towards term.
Since only small transplacental bleeds are anticipated be-
fore 30 weeks of pregnancy with more profuse bleed
generally occurring after this time," it is possible to con-
clude that a breakdown in protection can be induced by
the introduction of significant variations in the dosage of
Rh-positive red cells crossing the placental barrier after
30 weeks' gestation. This situation bears a striking resem-
blance to the inability of anti-D gammaglobulin to
secure complete protection against rhesus immunization
when massive foeto-maternal bleeds are encountered."'"
Such serological developments suggest that there are at
least 2 ways in which the intensity of increased Rh-anti-
body production can be stimulated during pregnancy. One
is the result of imperfectly understood defects of the pla-
centa, which allows greater quantities of foetal red cells
into the maternal circulation, while the other is un-
doubtedly closely associated with external version,"" the
repeated application of abdominal amniocentesis,"'lS or
certain modes of obstetric management during the third

























TABLE H. ANALYSIS OF FREQUENCY OF ANTENATAL EPISODES OF RH-
IMMUNIZATION OBSERVED AMONG 818 RH-IMMUNIZED MOTHERS
EXAMINED AT VARIOUS STAGES OF PREGNANCY
Episodes of Rh immunizatioll
observed*






pregnancy, or became immunized at some stage during the
present pregnancy. The findings observed for different
gestation periods clearly show that a significantly greater
frequency of episodes of increased Rh-antibody produc-
tion occurs after 32 weeks of gestation. Considering that
this probably indicates increased foetal red cell leakage
across the placental barrier, the results would appear to be
in agreement with the findings of Betke," who showed
that a greater percentage of foetal red cells is generally
observed in the maternal circulation towards the end of
pregnancy.
Since none of the Rh-immunized mothers studied in this
report was subjected to amniocentesis, it is intended 10
carry out comparative evaluations in future of the rate of
increased antibody production observed between mothers
not subjected to amniocentesis and those who were.
Table III records a similar investigation of 818 Rh-
immunized mothers, comparing those who were im-
. munized before the present pregnancy and those who were
not. Of importance here is the observation that the fre-
quency of raised episodes of immunization is significantly
greater among those mothers who showed the presence of
Rh antibodies for the first time. This increase appeared to
be closely associated with the duration of pregnancy,
showing that mothers not immunized before the present
pregnancy recorded a significantly greater frequency of
episodes of immunization before 35 weeks of pregnancy
than the Rh-negative mothers who were already im-
munized.
Since it would be unrealistic to assume that such dif-
ferences are directly influenced by significant variations
TABLE Ill. COMPARATIVE ANALYSIS OF FREQUENCY OF ANTENATAL EPISODES OF RH IMMUNIZATION OBSERVED AMONG MOTHERS OT IMM NIZED
AND THOSE ALREADY IMMUNIZED BEFORE PRESENT PREGNANCY
Mothers already immullized before
presellT pregnancy
Mothers not immunized before
present pregnancy Chi-square values
( YaTes correcTion applied)
Total No. ofmothers Episodes confirmed* Total No. ofmothers Episodes cOllfirmed*
Gestatioll range
No. % No. 0'0
25 weeks or less 208 0 610 0
26-28 weeks 208 27 12·9 610 26 4·2 x'(U 16'449 P = 0·001
29-31 weeks 208 43 20·6 597 63 10·5 x'(U 9·454 P = 0·01
32-34 weeks 208 62 29·8 565 104 18·4 x'w 6· 771 P = 0·01
35-37 weeks 200 87 43·5 513 167 32·5 X'(l) 3· 160 n.s.
38-40 weeks 167 109 65·2 122 58 47·5 x'm 2· 178 n.s.
Average for all gestations 199 54 27·1 502 69 13·7 x' 11·838 P = 0·001
• Represents Rh-antibody titre increase of 3 dilution tubes or more.
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TABLE IV. EVALUATION OF I 'CIDE CE OF fOETAL WASTAGE (STIl.LBIRTHS AND NEONATAL DEATHS) IN RELATION TO ANTENATAL EPISODES OF
INCREASED RH-ANTIBODY PRODUCTION OBSERVED FOR 208 MOTHERS WHO WERE NOT IMMUNIZED BEFORE PRESENT PREGNA 'CV
Antenatal episodes of immunization
Total No. of Observed* Not observed
Gestation rangf mothers
observed Foetal wastage Foetal wastagf
o. % No. % No. % No. %
25 weeks or less 208 0 0 0 0 208 100·0 0 0
26-28 weeks 208 27 12·9 0 0 181 87·1 0 0
29-31 weeks 208 43 20·6 0 0 165 73·4 0 0
32-34 weeks 208 62 29·8 0 0 146 70·2 0 0
35-37 weeks 200 87 43·5 2 2·3 113 56·5 0 0
38--40 weeks 167 109 65·2 5 4·6 58 34·8 I 1·7
* Represents Rb·antib::>dy titre increase of 3 dilution tubes or more.
TABLE V. EVALUATION OF INCIDENCE OF FOETAL WASTAGE (STILLBIRTHS AND NEONATAL DEATHS) IN RELATION TO ANTENATAL EPISODES OF
INCREASED RH-A 'TlBODY PRODUCTION OBSERVED FOR 610 MOTHERS WHO WERE ALREADY IMMUNIZED BEFORE PRESENT PREGNA 'CY
Antenatal episodes of immunization
Total No. of Observed* Not observed
Gestation range mothers
obferved Foetal wastage Foetal wastage
--------
No. % No. % No. % No. %
25 weeks or less 610 0 0 0 0 610 100·0 0 0
26-28 weeks 610 26 4·2 10 38·4 584 95·8 3 0·5
29-31 weeks 597 63 10·5 27 42·7 534 89·5 5 1·0
32-34 weeks 565 104 18·4 26 25·0 461 81·6 8 I· 7
35-37 weeks 513 167 32·5 49 29·3 346 67·5 21 6·0
38--40 weeks 122 58 47·5 8 13·7 64 52·5 3 4·6
* Represents Rh-antibody titre increase of 3 dilution tubes or more.
The results so far presented show that foetal red cells
often cross the placental barrier to stimulate increased Rh-
antibody production in the mother. Not firmly established,
however, is the effect of these episodes of immunization
on the clinical manifestation of Rh-haemolytic disease.
Table N details an analysis of 208 mothers who for the
first time showed Rh antibodies during an Rh-incompati-
ble pregnancy. It is interesting to note that foetal wastage
(combined stillbirths and neonatal deaths) can be antici-
pated in the first immunizing pregnancy. Thus, the ten-
dency to consider all primary immunization cases as mild-
ly affected infants, who generally do not require further
treatment, will involve a certain amount of risk unless
constant follow-up studies are carried out to measure the
intensity of the haemolytic process in utero.
Compared with the values of foetal wastage observed
among the already immunized series of mothers as shown
in Table V, it is significant that the foetal losses recorded
among the primary immunization cases consistently took
place after 35 weeks of pregnancy, when the incidence of
Rh-antibody stimulation appeared to be most intense. This
type of pattern also suggests that the time during which an
Rh-positive foetus is exposed to Rh antibodies is of some
importance ill determining the severity of the haemolytic
process in utero.
From the findings presented in Tables N and V it is
also evident that a very significant percentage of foetal
wastage can be directly attributed to the occurrence of re-
newed episodes of Rh-antibody stimulation. This implies
that the protective factor against increased Rh-antibody
formation in the already immunized mother can be re-
versed through the reactivities of progressively large
foetal bleeds, which in turn intensify the haemolytic pro-
cess.
SUMMARY
In a study of 818 Rh-immunized mothers investigated through-
out pregnancy it was shown that the frequency of raised Rh-
antibody production, as determined by a 3-fold increase in the
indirect antiglobulin titre, was significantly greater among
mothers who were not immunized before the present preg-
nancy than among those who were already immunized. This
type of variation appeared as evidence that increased Rh-anti-
body stimulation is not easy to induce when the already
immunized mother is subjected to small transplacental bleeds
of foetal Rh-positive red cells sensitized in wero. Foetal mor-
tality studies also showed that the occurrence of increased Rh-
antibody stimulation in the mother is directly responsible for a
large percentage of foetal wastage observed in Rh-hr.emolytic
disease of the newborn.
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